Markets:

Overview

News

Currencies

International

Treasuries

Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)

43.73 -0.46 (-1.04%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Supernus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

August 29, 2026

From Halper Sadeh LLC

Via Business Wire

3 Small-Cap Stocks with Open Questions

August 25, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

1 Healthcare Stock with Exciting Potential and 2 We Ignore

August 18, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Via StockStory

Topics Retirement

Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript ↗

August 17, 2026

Supernus Pharmaceuticals (NASDAQ:SUPN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs....

Via Benzinga

Topics Earnings

3 Russell 2000 Stocks We Approach with Caution

August 14, 2026

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Via StockStory

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

August 07, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Why Supernus Pharmaceuticals Stock Topped the Market Today ↗

August 03, 2026

It's effecting a "merger of equals" with a peer.

Via The Motley Fool

Halper Sadeh LLC is Investigating Whether SUPN, ITGR, BOW are Obtaining Fair Deals for their Shareholders

August 03, 2026

From Halper Sadeh LLC

Via GlobeNewswire

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

August 03, 2026

From Halper Sadeh LLC

Via Business Wire

Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗

August 03, 2026

Supernus Pharmaceuticals (NASDAQ:SUPN) and Indivior Pharmaceuticals announced a proposed all-stock, tax-free merger of equals that would create a central nervous system-focused biopharmaceutical...

Via MarketBeat

Topics Earnings

What's going on in today's pre-market session ↗

August 03, 2026

Via Chartmill

Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Q2 CY2026 Sales, Stock Jumps 24.9%

August 03, 2026

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 3...

Via StockStory

Supernus Announces Second Quarter 2026 Financial Results

August 03, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

August 03, 2026

From Supernus Pharmaceuticals, Inc.; Indivior Pharmaceuticals, Inc.

Via GlobeNewswire

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

August 02, 2026

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be reporting results this Tuesday after market hours. Here’s what to look for. S...

Via StockStory

Topics Artificial Intelligence

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026

July 22, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

July 16, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

1 Growth Stock to Stash and 2 We Turn Down

July 15, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

Via StockStory

Topics Artificial Intelligence

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

July 14, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest

June 22, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 of Wall Street’s Favorite Stocks We Approach with Caution

June 19, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

3 Reasons to Avoid SUPN and 1 Stock to Buy Instead

June 16, 2026

Over the last six months, Supernus Pharmaceuticals’s shares have sunk to $43.79, producing a disappointing 9.4% loss - a stark contrast to the S&P 500’s 9.3%...

Via StockStory

Topics Stocks Supply Chain

1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges

June 05, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Via StockStory

Supernus Pharmaceuticals to Participate in June Investor Conferences

May 27, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

3 Stocks Under $50 with Open Questions

May 21, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Via StockStory

3 Small-Cap Stocks That Concern Us

May 18, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

Topics Artificial Intelligence

3 Growth Stocks We Approach with Caution

May 15, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

Via StockStory

What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Year ↗

May 12, 2026

Supernus Pharmaceuticals delivers specialty therapies for CNS disorders, targeting healthcare providers and specialty pharmacies nationwide.

Via The Motley Fool

Topics Regulatory Compliance

5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call

May 12, 2026

Supernus Pharmaceuticals’ first quarter saw a positive market response, as management attributed the revenue growth to robust demand for its key growth produ...

Via StockStory

Topics Earnings Supply Chain

Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today

May 07, 2026

What Happened? Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 6.8% in the afternoon session after the company repor...

Via StockStory

Topics Earnings Economy

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.